Call Options Transactions Made in Q2 2023 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q2 2023. The information is specifically focused on institutions that hold call options of Aclaris Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
128KNew |
$1.01M - $1.36M
|
128K
$490K
|
|
|
Aug 14, 2023
Q2 2023
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
48K+ 676.06% |
$379K - $511K
|
55.1K
$210K
|
|
|
Aug 08, 2023
Q2 2023
|
Belvedere Trading LLC
|
BUY
|
CALL |
13.1K+ 689.47% |
$103K - $139K
|
15K
$57.3K
|
|
|
Aug 23, 2023
Q2 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-800- 4.35% |
$6.31K - $8.51K
|
17.6K
$67.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-9.5K- 8.1% |
$75K - $101K
|
108K
$412K
|
|
|
Aug 14, 2023
Q2 2023
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-23.1K- 69.58% |
$182K - $246K
|
10.1K
$38.6K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-222K- 60.46% |
$1.75M - $2.36M
|
145K
$554K
|